Special blood transfusions for premature newborns
Part of Blood & lymphatic clinical trials.
This trial tests whether using specially prepared blood from umbilical cords (enriched with fetal hemoglobin) works better for premature babies who need blood transfusions. The goal is to see if this approach reduces complications and the number of transfusions needed during hospitalization.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby was born prematurely between 24 and 31 weeks of pregnancy (not 32 weeks or later)
- Baby will need at least one red blood cell transfusion during their hospital stay
- Baby has not received any blood transfusions before enrollment in the study
- Baby does not have major birth defects or genetic conditions
- Mother did not have complications like hemolytic disease, fetal fluid buildup, or certain infections during pregnancy
- Baby did not have significant bleeding at delivery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether red blood cells made from donated cord blood are safe and effective for transfusions in extremely premature infants. It aims to see if this alternative blood source can help babies born before 28 weeks or weighing less than 1000 grams.
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
This trial looks at whether red blood cell transfusions are linked to health problems in very premature babies. It may help doctors better understand how to care for these infants.
This trial looks at whether it’s safer to temporarily withhold (pause) breast milk or formula feeds around the time of a blood transfusion in very premature babies. It may help reduce gut-related complications like NEC, a serious intestinal problem.
This study is testing whether giving smaller volumes of platelet transfusions to premature babies with very low platelet counts is as effective as the standard larger volume. It aims to find a safer way to prevent bleeding while reducing risks like fluid overload.
This study tests whether giving regular blood transfusions during early pregnancy can help prevent complications for women with sickle cell disease. If you are between 6 and 20 weeks pregnant, you may join to see if this treatment improves outcomes.
Hear when a new Prematurity Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.